21/07/2025
🔬 New scientific publication 🌟
We are pleased to share that the study “Clinical Outcomes and Optical Bench Analysis of a Novel Enhanced Monofocal Intraocular Lens” by Giovanni Romualdi et al. has been published in Life (vol. 15, no. 6, 2025).
👁️ Study Objective
To evaluate the clinical performance of the new Evolux enhanced range of vision IOL compared to the traditional monofocal IOL Tecnis GCB00 (J&J), enhancing intermediate vision without compromising distance vision or inducing photic phenomena.
📊 Methodology
• Prospective, single-center, comparative clinical study on 100 eyes
• Two groups:
o bilateral implantation of Tecnis GCB00
o bilateral implantation of Evolux
• Evaluated parameters: visual acuity (distance and intermediate), refractive predictability, contrast sensitivity, optical quality, spectacle independence
• Supported by optical bench analysis
✅ Key Results
• Evolux provided significantly better uncorrected and distance-corrected intermediate visual acuity (UIVA LogMAR 0.10 vs 0.26, p < 0.001)
• Comparable distance vision in both groups
• No increase in halos or reduction in contrast sensitivity
🔍 Conclusion
The new Evolux IOL offers a significant improvement in intermediate vision without sacrificing distance vision, representing a meaningful advance in cataract surgery.
📌 Congratulations to Giovanni Romualdi, Matilde Buzzi, Pier G. Ruggeri, Federico Tommasi, Alessio Giorgetti, Stefano Cavalieri, and Rita Mencucci on this achievement—a further step toward enhancing patients’ everyday visual experience! 🎯
Purpose: A novel enhanced monofocal intraocular lens (IOL) has been developed to improve functional intermediate vision, maintaining a distance vision comparable to a standard monofocal lens and avoiding the drawbacks of multifocal IOLs. The aim of this study is to perform optical bench analysis and...
